MANNKIND CORP Amortization of Debt Issuance Costs and Discounts
MANNKIND CORP (MNKD) reported Amortization of Debt Issuance Costs and Discounts of $866.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-05
- MANNKIND CORP amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $414.00K, a 279.82% increase year-over-year.
- MANNKIND CORP amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $452.00K, a 314.68% increase year-over-year.
- MANNKIND CORP amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $478.00K, a 52.72% increase year-over-year.
- MANNKIND CORP amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $158.00K, a 62.11% decline year-over-year.
- MANNKIND CORP amortization of debt issuance costs and discounts for fiscal 2025 was $854.00K, a 48.12% decline from fiscal 2024.
- MANNKIND CORP amortization of debt issuance costs and discounts for fiscal 2024 was $1.65M, a 21.06% decline from fiscal 2023.
- MANNKIND CORP amortization of debt issuance costs and discounts for fiscal 2023 was $2.08M, a 0.33% decline from fiscal 2022.
- MANNKIND CORP amortization of debt issuance costs and discounts for fiscal 2022 was $2.09M, a 22.41% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $414.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $866.00K 10-Q · filed 2026-08-05 | $1.34M derived: sum of 3 quarters · filed 2026-08-05 | $1.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $452.00K 10-Q · filed 2026-05-06 | $930.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.09M derived: sum of 3 quarters · filed 2026-05-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $636.00K derived: sum of 2 quarters · filed 2026-02-26 | $745.00K derived: sum of 3 quarters · filed 2026-08-05 | $854.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $267.00K derived: sum of 2 quarters · filed 2026-08-05 | $376.00K 10-Q · filed 2025-11-05 | $689.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $218.00K 10-Q · filed 2026-08-05 | $531.00K derived: sum of 3 quarters · filed 2026-08-05 | $948.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $109.00K 10-Q · filed 2026-05-06 | $422.00K derived: sum of 2 quarters · filed 2026-05-06 | $839.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.25M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $730.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.15M derived: sum of 3 quarters · filed 2026-02-26 | $1.65M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $832.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.33M 10-Q · filed 2025-11-05 | $1.85M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $916.00K 10-Q · filed 2025-08-06 | $1.43M derived: sum of 3 quarters · filed 2026-02-26 | $2.06M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $501.00K 10-Q · filed 2025-05-08 | $1.02M derived: sum of 2 quarters · filed 2026-02-26 | $1.65M derived: sum of 3 quarters · filed 2026-02-26 | $2.12M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.14M derived: sum of 2 quarters · filed 2026-02-26 | $1.62M derived: sum of 3 quarters · filed 2026-02-26 | $2.08M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.10M derived: sum of 2 quarters · filed 2024-11-07 | $1.57M 10-Q · filed 2024-11-07 | $2.10M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $941.00K 10-Q · filed 2024-08-07 | $1.47M derived: sum of 3 quarters · filed 2025-02-26 | $1.83M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $469.00K 10-Q · filed 2024-05-08 | $994.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.36M derived: sum of 3 quarters · filed 2025-02-26 | $1.72M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $888.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.25M derived: sum of 3 quarters · filed 2025-02-26 | $2.09M 10-K · filed 2025-02-26 | $1.45M 10-K · filed 2023-02-23 | |||
| 2022-09-30 | $363.00K 10-Q · filed 2022-11-08 | $726.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.57M 10-Q · filed 2023-11-07 | $1.09M 10-Q · filed 2022-11-08 | $2.05M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | $363.00K 10-Q · filed 2022-08-09 | $940.00K 10-Q · filed 2023-08-07 | $726.00K 10-Q · filed 2022-08-09 | $1.69M derived: sum of 3 quarters · filed 2024-02-27 | $2.05M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $469.00K 10-Q · filed 2023-05-09 | $363.00K 10-Q · filed 2022-05-05 | $1.33M derived: sum of 2 quarters · filed 2024-02-27 | $1.69M derived: sum of 3 quarters · filed 2024-02-27 | $2.05M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.22M derived: sum of 2 quarters · filed 2024-02-27 | $1.58M derived: sum of 3 quarters · filed 2024-02-27 | $1.71M 10-K · filed 2024-02-27 | $1.22M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $363.00K 10-Q · filed 2022-11-08 | $726.00K derived: sum of 2 quarters · filed 2022-11-08 | $852.00K 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $363.00K 10-Q · filed 2022-08-09 | $488.00K 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | $124.00K 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | $101.00K 10-K · filed 2023-02-23 | -$101.00K 10-K · filed 2021-02-25 | ||||||
| 2020-03-31 | -$27.00K 10-Q · filed 2020-05-06 | -$222.00K derived: sum of 2 quarters · filed 2021-02-25 | -$188.00K derived: sum of 3 quarters · filed 2021-02-25 | |||||
| 2019-12-31 | -$195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$161.00K derived: sum of 2 quarters · filed 2021-02-25 | -$111.00K 10-K · filed 2021-02-25 | |||||
| 2019-09-30 | $34.00K 10-Q · filed 2019-11-08 | $84.00K 10-Q · filed 2019-11-08 | ||||||
| 2019-03-31 | -$22.00K 10-Q · filed 2020-05-06 | -$138.00K derived: sum of 2 quarters · filed 2020-05-06 | -$116.00K derived: sum of 3 quarters · filed 2020-05-06 | |||||
| 2018-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$94.00K derived: sum of 2 quarters · filed 2020-02-25 | -$69.00K 10-K · filed 2020-02-25 | |||||
| 2018-09-30 | $22.00K 10-Q · filed 2019-11-08 | $47.00K 10-Q · filed 2019-11-08 | ||||||
| 2015-09-30 | $195.00K 10-Q · filed 2015-11-09 | $438.00K derived: sum of 2 quarters · filed 2015-11-09 | $673.00K 10-Q · filed 2015-11-09 | $895.00K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2015-06-30 | $243.00K 10-Q · filed 2015-08-10 | $481.00K 10-Q · filed 2015-08-10 | $700.00K derived: sum of 3 quarters · filed 2015-08-10 | $931.00K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2015-03-31 | $238.00K 10-Q · filed 2015-05-11 | $457.00K derived: sum of 2 quarters · filed 2015-05-11 | $688.00K derived: sum of 3 quarters · filed 2015-11-09 | $915.00K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2014-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $450.00K derived: sum of 2 quarters · filed 2015-11-09 | $677.00K derived: sum of 3 quarters · filed 2015-11-09 | $900.00K 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | $231.00K 10-Q · filed 2015-11-09 | $458.00K derived: sum of 2 quarters · filed 2015-11-09 | $681.00K 10-Q · filed 2015-11-09 | $944.00K derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2014-06-30 | $227.00K 10-Q · filed 2015-08-10 | $450.00K 10-Q · filed 2015-08-10 | $713.00K derived: sum of 3 quarters · filed 2015-08-10 | $929.00K derived: sum of 4 quarters · filed 2015-08-10 | ||||
| 2014-03-31 | $223.00K 10-Q · filed 2015-05-11 | $486.00K derived: sum of 2 quarters · filed 2015-05-11 | $702.00K derived: sum of 3 quarters · filed 2015-05-11 | $914.00K derived: sum of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $479.00K derived: sum of 2 quarters · filed 2015-03-02 | $691.00K derived: sum of 3 quarters · filed 2015-03-02 | $900.00K 10-K · filed 2015-03-02 | $1.40M 10-K · filed 2014-03-03 | |||
| 2013-09-30 | $216.00K 10-Q · filed 2014-11-10 | $369.00K 10-Q · filed 2013-11-12 | $428.00K derived: sum of 2 quarters · filed 2014-11-10 | $637.00K 10-Q · filed 2014-11-10 | $1.09M 10-Q · filed 2013-11-12 | $406.00K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $212.00K 10-Q · filed 2014-08-11 | $364.00K 10-Q · filed 2013-08-09 | $421.00K 10-Q · filed 2014-08-11 | $722.00K 10-Q · filed 2013-08-09 | $190.00K derived: sum of 3 quarters · filed 2015-03-02 | $538.00K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $209.00K 10-Q · filed 2014-05-12 | $358.00K 10-Q · filed 2013-05-10 | -$22.00K derived: sum of 2 quarters · filed 2015-03-02 | $326.00K derived: sum of 3 quarters · filed 2015-03-02 | $669.00K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $117.00K derived: sum of 2 quarters · filed 2015-03-02 | $460.00K derived: sum of 3 quarters · filed 2015-03-02 | $800.00K 10-K · filed 2015-03-02 | $1.40M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $348.00K 10-Q · filed 2013-11-12 | $691.00K derived: sum of 2 quarters · filed 2013-11-12 | $1.03M 10-Q · filed 2013-11-12 | $1.36M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-06-30 | $343.00K 10-Q · filed 2013-08-09 | $682.00K 10-Q · filed 2013-08-09 | $1.01M derived: sum of 3 quarters · filed 2014-03-03 | $1.34M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-03-31 | $339.00K 10-Q · filed 2013-05-10 | $666.00K derived: sum of 2 quarters · filed 2014-03-03 | $995.00K derived: sum of 3 quarters · filed 2014-03-03 | $1.32M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2011-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $656.00K derived: sum of 2 quarters · filed 2014-03-03 | $980.00K derived: sum of 3 quarters · filed 2014-03-03 | $1.30M 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | $329.00K 10-Q · filed 2012-11-09 | $653.00K derived: sum of 2 quarters · filed 2012-11-09 | $973.00K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $324.00K 10-Q · filed 2012-08-09 | $644.00K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |